Trial Profile
A Phase 3, Open Label, Randomized, Comparative Study To Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Jun 2015
Price :
$35
*
At a glance
- Drugs Chloroquine/azithromycin (Primary) ; Pyrimethamine/sulfadoxine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors Pfizer
- 07 Nov 2014 New trial record